A detailed history of Algert Global LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Algert Global LLC holds 50,702 shares of VCYT stock, worth $1.08 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
50,702
Previous 99,085 48.83%
Holding current value
$1.08 Million
Previous $2.73 Million 58.77%
% of portfolio
0.04%
Previous 0.11%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$21.0 - $29.1 $1.02 Million - $1.41 Million
-48,383 Reduced 48.83%
50,702 $1.12 Million
Q4 2023

Feb 14, 2024

BUY
$19.72 - $28.68 $547,032 - $795,583
27,740 Added 38.88%
99,085 $2.73 Million
Q3 2023

Nov 13, 2023

BUY
$22.33 - $29.92 $433,737 - $581,166
19,424 Added 37.41%
71,345 $1.59 Million
Q2 2023

Aug 14, 2023

SELL
$20.96 - $26.99 $674,660 - $868,754
-32,188 Reduced 38.27%
51,921 $1.32 Million
Q1 2023

May 12, 2023

BUY
$20.58 - $27.89 $1.42 Million - $1.92 Million
68,964 Added 455.36%
84,109 $1.88 Million
Q3 2022

Nov 15, 2022

SELL
$16.58 - $27.9 $21,139 - $35,572
-1,275 Reduced 7.76%
15,145 $251,000
Q2 2022

Aug 15, 2022

BUY
$15.45 - $29.52 $253,689 - $484,718
16,420 New
16,420 $327,000
Q4 2021

Feb 14, 2022

SELL
$36.09 - $53.79 $246,025 - $366,686
-6,817 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$35.62 - $52.97 $242,821 - $361,096
6,817 New
6,817 $317,000
Q1 2020

May 13, 2020

SELL
$16.13 - $30.17 $149,525 - $279,675
-9,270 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$20.78 - $29.99 $192,630 - $278,007
9,270 New
9,270 $259,000
Q3 2019

Nov 14, 2019

SELL
$23.87 - $30.93 $1.13 Million - $1.46 Million
-47,180 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$22.1 - $28.56 $229,707 - $296,852
-10,394 Reduced 18.05%
47,180 $1.35 Million
Q1 2019

May 01, 2019

SELL
$12.0 - $25.76 $908,052 - $1.95 Million
-75,671 Reduced 56.79%
57,574 $1.44 Million
Q4 2018

Feb 01, 2019

SELL
$9.15 - $14.85 $715,456 - $1.16 Million
-78,192 Reduced 36.98%
133,245 $1.68 Million
Q3 2018

Nov 14, 2018

BUY
$9.55 - $12.64 $859,375 - $1.14 Million
89,987 Added 74.09%
211,437 $2.02 Million
Q2 2018

Aug 02, 2018

SELL
$5.39 - $9.66 $76,133 - $136,447
-14,125 Reduced 10.42%
121,450 $1.13 Million
Q1 2018

May 03, 2018

SELL
$5.44 - $6.97 $372,819 - $477,675
-68,533 Reduced 33.58%
135,575 $754,000
Q4 2017

Feb 01, 2018

BUY
$6.05 - $9.37 $563,853 - $873,274
93,199 Added 84.03%
204,108 $1.33 Million
Q3 2017

Nov 17, 2017

BUY
$7.81 - $8.77 $866,199 - $972,671
110,909
110,909 $973,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.52B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.